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Cyanotoxins are secondary metabolites produced by cyanobacteria. They pose a threat to human health 
and the environment. This review summarises the existing data on human exposure to cyanotoxins through 
drinking water, recreational activities (e.g., swimming, canoeing or bathing), the aquatic food web, terrestrial 
plants, food supplements, and haemodialysis. Furthermore, it discusses the tolerable daily intake and 
guideline values for cyanotoxins (especially microcystins) as well as the need to implement risk management 
measures via national and international legislation.
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Cyanobacteria, also known as blue green algae, 
are present in many water ecosystems. Their increased 
growth is referred to as cyanobacterial bloom (1). 
Large cyanobacterial blooms are classified as 
“harmful” when they lead to negative environmental 
impacts such as mortality, ecosystem instability, and 
the production of highly active toxic compounds 
known as cyanotoxins (2). Cyanotoxins are diverse in 
chemical structure and toxicity. Depending on the 
human organ affected, cyanotoxins are classiﬁ ed as 
h e p a t o t o x i n s  ( m i c r o c y s t i n s ,  n o d u l a r i n , 
cylindrospermopsin), neurotoxins (saxitoxins, 
anatoxin-a, anatoxin-a(s), homoanatoxin-a), cytotoxins 
(aplysiatoxin, debromoaplysiatoxin, lingbyatoxin, 
l ipopolysaharide endotoxin),  and skin and 
gastrointestinal irritants (3, 4). The most common 
cyanotoxin group are microcystins (MCs) (1), while 
microcystin-LR (MC-LR) is their most toxic structural 
variant (5). Toxic cyanobacteria and their toxic 
metabolites pose a health hazard to plants and animals 
(6, 7). These toxins can also cause illnesses in humans 
(8, 9), or even death when one is exposed through 
haemodialysis (10). Following exposure to cyanotoxins, 
symptoms such as abdominal pain, vomiting, 
diarrhoea, skin irritation, weakness, sore throat, pale 
mucous membrane, and muscle tremors were observed 
in animals and humans (1). MCs require additional 
attention, not only for their ability to cause acute 
poisoning, but also for their ability to initiate cancer 
through acute doses and potentially promote it through 
chronic exposure to low MC concentrations in 
drinking water (9, 11, 12). In 2006 in Lyon, France, 
the International Agency for Research on Cancer 
(IARC), performed an assessment of the cancerogenesis 
of MC-LR and concluded that MC-LR is a possible 
carcinogen for humans, classifying it as a group 2B 
carcinogen (13). The health threats caused by 
cyanotoxins, especially MCs, have led the World 
Health Organization (WHO) to establish a tolerable 
daily intake (TDI) (0.04 μg kg-1) and a provisional 
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guideline value for MC-LR in drinking water (1 μg L-1) 
(14). Also, guidance values for other exposure 
pathways such as recreational water, food, and 
supplements, were established (15). Some countries 
accepted the stated values (the Czech Republic, 
France, Japan, Korea, New Zealand, Norway, Poland, 
Brazil, and Spain), while others formulated their own 
values, depending on the local conditions (Australia, 
Canada). The most pervasive legislation was 
introduced in Brazil, setting the mandatory standard 
to 1 μg L-1 for MCs, and the recommended values for 
saxitoxins and cylindrospermopsin to 3 μg L-1 and 
15 μg L-1, respectively (16).
This review focuses on the cyanobacterial toxicity 
and cyanotoxin accumulation in various aquatic 
organisms, edible plants, dietary supplements, and 
drinking water supplies as probable pathways for 
toxins to reach humans. A possible derivation and 
implementation of guideline values for these 
cyanotoxins is also discussed.
Routes of exposure
The major routes of human exposure to cyanotoxins 
are: chronic and accidental ingestion of contaminated 
drinking water; inhalation or contact with the nasal 
mucous membrane, and dermal contact with toxins 
during recreational activities such as swimming, 
canoeing or bathing; consumption of contaminated 
vegetables and fruits irrigated with water containing 
cyanotoxins; consumption of aquatic organisms (ﬁ sh, 
shellﬁ sh, etc.) from contaminated waters; oral intake 
of cyanobacterial dietary supplements (if cyanotoxin 
levels are not controlled); and the speciﬁ c intravenous 
route caused by dialysis.
Ingestion of contaminated drinking water
Direct ingestion of contaminated drinking water is 
a frequent route of cyanotoxin intake. If the water is 
obtained from a surface water source during 
cyanobacterial bloom, it is possible that the water had 
become contaminated with toxins released during cell 
decomposition (1). There are numerous cases of 
cyanobacterial toxins detected in raw and ﬁ nal water 
throughout the world (Argentina, Australia, Bangladesh, 
Canada, Czech Republic, China, Finland, France, 
Germany, Latvia, Poland, Thailand, Turkey, Spain, 
Switzerland, USA) (15, 17-19). High levels of risk to 
human health are linked to the ingestion of large 
cyanotoxin quantities from water or the intake of small 
doses during extended chronic exposure (20).
Hepatotoxins in drinking water could be a risk 
factor for primary liver cancer (PLC), but only a 
limited number of epidemiological studies have 
confronted this issue. The prevailing opinion in the 
literature is that the development of PLC results from 
cirrhosis and chronic viral hepatitis (HBV and HCV). 
However, this could not be concluded from the 
obtained data on the incidence of PLC, HBV, HCV, 
and liver cirrhosis mortality in central Serbia from 
2000 to 2006; no correlation between PLC and these 
diseases was found (21). On the other hand, 
epidemiological studies in Serbia have shown that the 
consumption of drinking water contaminated by MCs 
could be connected to human PLC (9, 20, 22). 
Similarly, a relationship between an increased risk of 
PLC and the quality of surface water was detected by 
Fleming et al. (23) in Florida. This kind of analysis 
was also conducted in China, where some authors (24) 
suggested that hepatotoxins from water reservoirs 
containing cyanobacteria triggered the development 
of PLC. Based on these reports, MCs could be an 
important chemical and external factor in the 
development of PLC.
Dermal contact and exposure through inhalation
Dermal contact occurs in recreational waters which 
endure the presence of cyanobacterial blooms. A wide 
range of symptoms associated with recreational 
exposure to cyanobacteria have been described: 
desquamation, skin rashes, asthma, pneumonia, dry 
sporadic cough with vomiting and other gastro-
intestinal symptoms, hay fever, conjunctivitis, ear and 
eye irritation, allergic reactions, and acute illnesses 
with symptoms such as severe headache, myalgia, 
vertigo, and blistering in the mouth. These symptoms 
were reported in the coastal waters of Japan, Hawaii, 
Australia, and Florida (25-28). Freshwater 
cyanobacterial blooms have also caused similar 
symptoms after swimming or water contact sports 
(29).
The cyanobacterial mats that form on the surface 
of coastal waters get broken apart by waves. Persons 
swimming in the affected waters collect cyanobacterial 
ﬁ laments under their bathing suits. The cells that 
accumulate under the fabric may come in contact with 
the skin and lead to skin irritation (30). “Swimmer’s 
itch” is a severe contact dermatitis which occurs after 
swimming in marine waters that contain speciﬁ c 
cyanobacterial blooms (e.g., Lyngbia majuscula). 
Within a period ranging from a few minutes to a few 
hours, itching and burning occurs. Visible dermatitis 
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and redness develop after tree to eight hours, followed 
by blisters and deep desquamation (31).
During recreation, one potential exposure route 
is inhalation. Respiratory distress has been reported 
after exposure to certain marine and freshwater blooms 
(7, 32, 33). Intranasal administration of MC-LR to 
mice has led to liver damage and extensive necrosis 
of the olfactory and respiratory zone epithelium. 
Moreover, the sensitivity was approximately 10 times 
greater than through oral exposure (34). Therefore, 
potential exposure to cyanotoxins through inhalation 
should not be ignored during showering, water sports 
(particularly water-skiing), and work practices 
involving agricultural or industrial spray water (29).
Also, cyanobacteria are vital primary producers in 
desert environments. Samples from dry, ephemeral 
river beds, and supertidal salt ﬂ ats in Qatar were 
analysed for cyanotoxins. Based on the level of MCs 
detected in the crust of all samples (at mass fractions 
between 1.5 ng g-1 and 53.7 ng g-1), the amount of dust 
inhaled by a person could have surpassed the TDI 
value of 1 ng to 2 ng of MCs per kilogram per day for 
an average adult. The presence of MCs, and potentially 
anatoxin-a(s), in desert crusts has substantial 
implications for the human health (35).
Terrestrial and aquatic plants
Crops can come into contact with cyanotoxins 
when surface water bodies containing cyanobacteria 
are used for spray irrigation or watering. Consequently, 
both plant yield and quality are affected. Furthermore, 
if the MC absorption exceeds the recommended 
tolerable limits, the affected plant might pose a risk 
for human and animal health (36).
Previous research has revealed that cyanotoxins 
can have negative effects on plants (37-40). Seedling 
exposure to cyanotoxins can cause growth inhibitions 
in a variety of terrestrial plants (41-44). The growth, 
development, photosynthetic activity, productivity, 
and mineral nutrition of wheat (Triticum durum), 
maize (Zea mays), pea (Pisum sativum), and lentil 
(Lens esculenta) cultivars was also found to be 
diversely affected by a cyanobacterial extract with 
MC-LR (36). It was also noted that, both submerged 
and emergent, aquatic plants absorb MC-LR from low 
external concentrations, and accumulate it in the shoot 
tissue (39, 45, 46). Furthermore, when exposed to 
MC-LR, aquatic plants exhibited an inhibition of 
growth and photosynthetic oxygen production, while 
their chlorophyll pigments became bleached (47).
Previous studies have shown that MC can be 
detected in the tissues of exposed terrestrial and 
aquatic plants (38, 40, 42, 43, 45, 48-50). Based on 
the results of a glasshouse experiment, when a 60 kg 
individual consumes 65 g to 75 g of fresh weight salad 
(6.8 g to 7.9 g dry weight), made with lettuce irrigated 
by lake water containing MCs, he/she also ingests 
approximately 5.8 μg of MCs per meal (0.10 μg kg-1 
of body weight). This level is above the provisional 
WHO TDI of 0.04 μg kg-1 b.w. per day for MC-LR 
consumed throughout a lifetime (51). One study 
conﬁ rmed that shoot cultures of apple (Malus pumila) 
accumulated an MC concentration of as much as 
(510.23±141.10) ng equivalents of MC-LR per gram 
of fresh weight after 14 days of exposure to 3 μg mL-1 
of MCs (52). Peuthert et al. (53) documented the 
uptake of MC-LR and MC-LF by the seedling roots 
of 11 agricultural plants, along with their ability to 
translocate them to the shoots. The MCs recovered 
from the exposed plants suggested that, when MC-
containing water is used for irrigation, terrestrial plants 
exhibit toxic effects on the human health (52).
In rice ﬁ elds, cyanobacteria can ﬁ xate nitrogen 
from the atmosphere and provide an important 
nitrogen source for rice plants (54). However, the MC 
uptake mechanisms of rice plants are not yet fully 
understood, which makes it hard to grasp the full 
impact of cyanotoxin exposure on human health.
Cyanobacterial toxicity through the aquatic food 
web
The bioaccumulation of cyanotoxins can occur in 
a wide range of aquatic animals used for human 
consumption. MCs were detected in freshwater 
shrimps (Palemon modestus, Macrobrachium 
nipponensis), and red swamp crayﬁ sh (Procamburus 
clarkii) (55, 56), while in the marine environment, 
saxitoxins were detected in pearl oysters (Pinctada 
maxima) (57). Also, cylindrospermopsin was found 
in bivalve hemolymphs, viscera, gonads, and feet (58). 
Saxitoxins from the Anabaena circinalis species can 
accumulate in Australian freshwater mussels after only 
one week of exposure to a cell density of 100,000 cells 
per millilitre, which usually occurs during this species’ 
bloom (59). Furthermore, MC was detected in the 
hepatopancreas, viscera, gonad, gill, and foot of the 
freshwater snail Bellamya aeruginosa (60). Chen et 
al. (60) found that most toxins are located in the 
inedible parts, which means that removing the 
hepatopancreas, digestive tract, and gonads before 
consumption could decrease the risk of intoxication. 
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However, since for instance snails are usually boiled 
whole, this creates a pathway for the ingestion of MCs. 
Furthermore, it should be noted that boiling does not 
destroy most of the known cyanobacterial toxins (15). 
White et al. (61) found cylindrospermopsin in another 
freshwater snail species (Melanoides tuberculata), 
generally not used in the human diet. Nonetheless, the 
aquatic food chain and bioaccumulation enables 
cyanotoxins to ultimately reach humans.
Being at the very top of the aquatic food chain, 
ﬁ sh are probably the most exposed to cyanotoxins, 
which may accumulate in the liver, muscles, gills, 
guts, and kidneys (62). Fish are exposed through 
feeding or breathing (63). MCs are actively taken up 
by the liver, disrupting normal cellular activity by 
inhibiting protein phosphatases (64, 65), which are 
particularly important during ﬁ sh embryogenesis, 
since they regulate critical developmental processes 
(66).
In early stages of life, exposure to MCs can disrupt 
normal embryonic hatching, decrease the survival and 
growth rate, and cause certain histopathological effects 
(enlarged and opaque yolk sac, small head, curved 
body and tail,  hepatobiliary abnormalities, 
ultrastructural alterations in hepatocytes, heart rate 
perturbations). In adults and juveniles, MC exposure 
can inﬂ uence the growth rate and osmoregulation, 
increase the heart rate and liver enzyme activity in the 
serum, alter behaviour, and cause histopathological 
changes in the liver, intestines, kidneys, heart, spleen, 
or gills. These abnormalities vary depending on the 
cyanotoxin dose and exposure routes (63). When 
exposed to a lower MC concentration (10 μg L-1 and 
100 μg L-1), carp hepatocytes died through apoptosis, 
whereas when a higher one was applied (1000 μg L-1), 
they died through necrosis (67). Histopathological 
analysis showed that cyanobacterial toxins are capable 
of killing ﬁ sh (68).
Furthermore, it was observed that MCs primarily 
accumulate in ﬁ sh livers, but can also be detected in 
muscles and viscera (63). MC concentrations are often 
highest in the gut and liver, lower in kidneys and 
gonads, and the lowest in muscle tissue (69-71). Romo 
et al. (72) investigated toxin accumulation in the ﬁ sh 
tissues of the commercial species Liza sp. They found 
high MC concentrations in the liver, intestines, gills 
and muscles. Moreover, the mean MC concentration 
in the muscles corresponded to a daily intake of 
0.025 μg kg-1, while 13 % of the analysed specimens 
had values above the recommended guideline 
concentration. On average, 200 tons of Liza sp. is sold 
each year, which is, based on the mean MC value in 
this study, equivalent to nearly 350 mg of MCs (5 ng
g-1 ﬁ sh muscle). This amount is potentially even greater 
if we consider that birds and other animals feed on 
ﬁ sh (72). However, new studies have shown that MC 
biodilution is the prevailing process in aquatic food 
webs, consistent across groups of aquatic consumers 
with the exception of zooplankton and zooplanktivorous 
ﬁ sh (73). Still, more thorough research is needed on 
this subject.
Cyanotoxin accumulation in ﬁ sh tissue may pose 
a risk to human health. The risks associated with 
consuming aquatic products were evaluated by 
analysing 26 of the most frequently consumed ﬁ sh 
and shellﬁ sh species from three large lakes in China. 
The results indicated that most of the aquatic products 
from these lakes seemed to have been unsafe for 
human consumption due to MC accumulation, with 
the estimated daily intake values being 1.5 to 148 times 
higher than the TDI (74). The distribution and 
bioaccumulation of MCs in Carassius gibelio was 
surveyed in 13 Greek lakes. MCs were found in livers, 
intestines, kidneys, brains, ovaries, and muscles. MC 
average values in ﬁ sh muscles were (7.1±2.5) ng g-1, 
while the concentrations found in several lakes 
exceeded the WHO TDI. According to the authors, a 
healthy 60 kg person who consumed a 300 g serving 
of C. gibelio on average daily would be at risk, even 
more so in the case of the elderly, children, or 
sensitive individuals (75).
The Wild Nile and redbreast tilapia (Oreochromis 
niloticus and Tilapia rendalli) were sampled at the 
Brazilian eutrophic stations of the Funil and Furnas 
reservoirs. All of the sampled ﬁ sh contained MCs 
(from 0.8 μg g-1 to 32.1 μg g-1 liver; from 0.9 ng g-1 to 
12.0 ng g-1 muscle). Among the 27 ﬁ sh examined at 
both reservoirs, 26 % (all O. Niloticus) were above 
the WHO TDI. Furthermore, even though the MC 
concentrations (986 ng L-1 at the Funil and 941 ng L-1 
at the Furnas reservoir) were below the WHO guideline 
for drinking water, the MCs in the ﬁ sh had accumulated 
to toxic levels (76).
It has also been found that different species of ﬁ sh 
accumulate different amounts of MCs. One study 
found the MC content in the liver and muscle to be 
highest in carnivorous ﬁ sh, followed by omnivorous 
ﬁ sh, while the lowest was in phytoplanktivorous and 
herbivorous fish. MCs can therefore accumulate 
upwardly in the food chain (71). In another study, 
MCs in the livers and guts were highest in 
phytoplanktivorous ﬁ sh, followed by omnivorous and 
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carnivorous ﬁ sh. On the other hand, MCs in muscles 
w e r e  h i g h e s t  i n  o m n i v o r o u s  f i s h ,  t h e n 
phytoplanktivorous, and ﬁ nally in carnivorous ﬁ sh 
(77). It is obvious that the feeding style of a ﬁ sh and 
the cyanotoxin accumulation in its tissue still cannot 
be clearly interrelated (78).
An investigation of cylindrospermopsin 
bioaccumulation in the muscle tissue of the redclaw 
crayﬁ sh (Cherax quadricarinatus) and the visceral 
tissues of the rainbow ﬁ sh (Melanotaenia eachamensis) 
showed that exposure to this toxin may occur in 
aquaculture ponds (79). The accumulation of 
saxitoxins was investigated by monitoring cyanotoxin 
levels in the liver and muscle samples of Oreochromis 
niloticus, showing that the Wild Nile tilapia is capable 
of bioaccumulating saxitoxins (80). A recent study 
at Lake Catemaco (Veracruz, Mexico), a lake with 
extensive Cylindrospermopsis blooms throughout the 
year, showed a presence of cylindrospermopsin and 
saxitoxins in ﬁ nﬁ sh species used for local consumption, 
and also indicated possible bioaccumulation (81). Due 
to this potential presence of cyanotoxins in edible 
aquatic organisms, toxic cyanobacteria blooms in 
aquacultures could pose a risk to ﬁ sh quality and, 
consequently, affect public health. Recently, a more 
comprehensive review was published on this topic 
(82).
Cyanobacterial dietary supplements
Cyanobacteria intake can also be voluntary, mostly 
for its rich protein content (e.g., Spirulina, Nostoc, 
and Aphanizomenon ﬂ os-aquae). Blue green algae 
supplements (BGAS) are mainly sold in industrialised 
countries, due to their beneﬁ cial health effects such 
as detoxiﬁ cation, weight loss, elevated mood and 
energy, and increased alertness (83, 84). Furthermore, 
some of these products are used in the pharmacological 
therapy of Attention Deﬁ cit Hyperactivity Disorder 
in children (85).
These products come in the form of pills, capsules, 
and powders, and can be consumed without any 
medical consultation. Since these products are natural, 
it is assumed that they are safe, and therefore BGAS 
may be taken at high doses and over a long period of 
time. However, they can have negative health effects, 
including symptoms such as nausea, vomiting, and 
diarrhoea. Although gastro-intestinal disturbance can 
be associated with BGAS consumption, it is usually 
attributed to the “detoxiﬁ cation” of the body. Also, 
certain potentially adverse effects can go unrecognized, 
while in many cases, the causative agent(s) and 
toxicity mechanisms are unclear (86).
However, traces of cyanotoxins have been found 
in BGAS products. Despite the general opinion that 
Spirulina is not toxic, epoxyanatoxin-a and 
dihydrohomoanatoxin-a have been identiﬁ ed in a 
Spirulina-based BGAS (87). Also, it was found that 
Spirulina fusiformis can produce low concentrations 
of MCs and anatoxin-a (88, 89). In addition, the 
Spirulina-based BGAS was suspected to cause liver 
damage in a middle-aged Japanese person (90). The 
Aph. flos-aquae species was found to produce 
anatoxin-a (91) and saxitoxins (92, 93), as well as 
BMAA (β-Methylamino Alanine) (94). A. ﬂ os-aquae 
is generally harvested from natural lakes, where it 
coexists with other cyanobacterial species such as 
Microcystis sp. (83), which implies that BGAS 
consumers may be exposed to MCs and other 
toxins.
Several independent investigations reported high 
MC levels in BGAS products (95-98), sometimes even 
higher than the provisional guidance value of 1 μg g-1 d.
w. set by the Oregon Health Division and Oregon 
Department of Agriculture (86). In studies from 2000 
and 2001, before awareness generally increased and 
regulations started being implemented, MC levels in 
BGAS products reached as much as 35 μg g-1 d.w. (86, 
95). In the German and Swiss markets, 8 out of 13 
BGAS products exceeded 1.0 μg equiv of MC-LR per 
gram d.w. (97). However, it is important to stress that 
not all BGAS products contain high MC concentrations, 
and that certain brands are known to have different 
MC concentrations from batch to batch (86, 97).
The Oregon provisional tolerable level for MCs in 
BGAS (1.0 μg g-1 MC-LR of dry weight) was 
calculated for adults, which means that children could 
be even more susceptible to MCs. Apart from the body 
weight of a consumer, guidance values for MC-LR 
are also inﬂ uenced by the daily amount of BGAS 
consumed, which largely depends on the individual, 
and can range from 0.25 g to 20 g (86, 99). Therefore, 
a daily consumption of several grams, which may 
contain from 1 μg equivalent to 35 μg equivalent 
MC-LR per gram of dry weight (96), could exceed 
the TDI and lead to long-term health problems. 
However, these could be avoided with more frequent 
control of BGAS products for cyanotoxin contamination 
and a decrease in the present guidance values. Based 
on these data, BGAS products can pose a health threat 
to consumers, especially children, so this exposure 
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pathway should receive more attention in future 
research.
The intravenous route
In 1996, an incident took place at the haemodialysis 
centre in Caruaru, Brazil. After a routine haemodialysis 
treatment, most patients (116 out of 131) experienced 
visual disturbances, nausea, vomiting, and muscle 
weakness. After a period of time, one hundred patients 
developed acute liver failure, and the “Caruaru 
Syndrome” lead to 52 fatalities. MCs were detected 
in all of the patient serum and liver tissue samples, 
while cylindrospermopsin was found in the carbon 
and resins from the clinic’s water treatment system. 
Moreover, cyanobacteria had a powerful presence in 
the local water reservoirs. Finally, it was concluded 
that the main contributing factor to the death of these 
patients was intravenous exposure to MCs (MC-YR, 
MC-LR and MC-AR). In 2000, cyanobacteria and 
cyanotoxins were incorporated into Brazilian 
legislation regarding the quality of drinking water 
(100).
DISCUSSION
For certain critical routes of exposure, the WHO 
and certain other institutions provided guideline values 
for MC-LR based on the tolerable daily intake. The 
TDI is the amount of a potentially harmful substance 
that can be consumed daily over a lifetime with 
negligible risk of adverse health effects. The guideline 
value for MC-LR was derived from a 13-week mouse 
oral study with pure MC-LR. Based on the liver 
histopathology and serum enzyme level changes, a 
NOAEL (no-observed adverse effect level) of 
40 μg kg-1 b.w. per day was determined (101). By 
applying a total uncertainty factor of 1000 (10 for 
intra-species variability, 10 for inter-species variability 
and 10 for limitations in the database), a provisional 
TDI of 0.04 μg kg-1 b.w. per day was calculated for 
MC-LR. Then, a proportion of the total intake from 
various sources of exposure (e.g., drinking water, food, 
etc.), often termed allocation factors, was multiplied 
by the body weight of a standardized adult (60 kg or 
70 kg) and the TDI, and then divided by the daily 
intake of the source (e.g., 2 L drinking water, 0.1 kg 
ﬁ sh, 2 g BGAS).
However, it would be advisable to revise the 
obtained guideline values. Although the main target 
for MCs is the liver, it can affect other organs, such 
as the colon (11, 102), intestines (103), brain (104, 
105), lungs (105, 106), heart (107), kidneys (108-110), 
and reproductive system (111, 112). Also, over 90 
analogues of MCs have been identiﬁ ed (113) and 
found to be toxic, but are not presently monitored. 
Nonetheless, a given species of cyanobacteria can 
produce a variety of potent cyanotoxins, and for most 
of them, the TDI cannot be derived due to a lack of 
toxicological data. So far, research on cyanobacterial 
carcinogenicity and tumour promotion has mainly 
focused on hepatotoxins (e.g., MC, nodularin, and 
cylindrospermopsin). However, cyanobacteria could 
also produce other metabolites with potential tumour-
promoting effects (114). Furthermore, a difference in 
the detected toxin concentration arises when diverse 
methods are applied. Current detection methods allow 
only the estimation of cyanotoxin concentrations due 
to their various limitations (e.g., sensitivity/selectivity), 
while most methods only measure free MCs (MCs 
that are not covalently-bound). Therefore, more 
precise and more reliable detection methods are 
necessary to derive adequate guideline values (15).
The level of risk to the human health depends on 
the cyanotoxin levels and exposure pathways. In a 
recent study, MCs were detected in the serum samples 
(average 0.39 ng mL-1) of fishermen from Lake 
Chaohu (China). The randomly chosen ﬁ sherman (14 
male and 21 female) lived on the lake from 5 to over 
10 years. During this period of time, they drank water 
from the lake and ate mostly aquatic products (ﬁ sh, 
shrimp, and snails). The daily intake by the ﬁ shermen 
was estimated to be within the range from 2.2 μg to 
3.9 μg MC-LReq, whereas the provisional WHO TDI 
for a daily lifetime exposure is 2 μg to 3 μg per person 
(115). The aforementioned data bring to question if 
extended exposure within the range of the TDI may 
still present a health risk.
Bearing in mind the possible chronic processes of 
accumulation in the human body, another issue should 
not be neglected: What kind of consequences does 
long-term exposure through different routes (drinking 
water, soup, fish soup, fish meat and seafood, 
supplements, consumption of vegetables after 
irrigation, recreational water activities, showering, 
etc.) have on the human health when cyanotoxin levels 
are elevated or even within the tolerable range? To 
prevent any potential risks, guideline values for 
cyanotoxins should be reviewed in light of more recent 
publications, particularly on potential exposure 
through food, and implemented into national 
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regulations taking local exposure patterns into account. 
Also, it is recommended to improve sample preparation 
and detection methods for cyanotoxins, as well as the 
continuous monitoring of water, food, and BGAS 
products. But most importantly, it is necessary to 
control eutrophication, and subsequently reduce 
cyanobacterial growth and exposure to cyanotoxins.
CONCLUSION
This review has shown that humans can be 
exposed to cyanotoxins through various routes. The 
accumulation of cyanotoxins, particularly MCs, in 
some aquatic animals, edible plants, and dietary 
supplements raised awareness about the importance 
of food as an exposure route by which MCs can enter 
the human body. The precise doses of these toxins are 
still an open issue which should be solved in order to 
prevent possible health risks. Therefore, the formulation 
and implementation of risk management measures via 
national and international legislation is necessary to 
preserve aquatic environments as well as the human 
health.
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Sažetak
PUTEVI IZLOŽENOSTI LJUDI CIJANOTOKSINIMA I NJIHOVI UTJECAJI NA ZDRAVLJE
Cijanotoksini su sekundarni metaboliti potencijalno opasni za ljudsko zdravlje i okoliš, koje proizvode 
cijanobakterije. Ovaj pregledni rad donosi prikaz postojećih podataka o izloženosti ljudi cijanotoksinima 
putem vode za piće, rekreacije, vodenog hranidbenog lanca, kopnenih biljaka i nekih drugih speciﬁ čnih 
puteva (dodaci prehrani i intravenozni put). Nadalje, u njemu se raspravlja o dopuštenom dnevnom unosu 
(TDI) i preporučenim vrijednostima za cijanotoksine (naročito mikrocistine) i nužnost provedbe mjera 
upravljanja rizicima putem nacionalnih i međunarodnih zakona. To su mjere od najveće važnosti za očuvanje 
okoliša i ljudskog zdravlja.
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